Current position of the management of community-acquired acute maxillary sinusitis or rhinosinusitis in France and literature review

Rhinology

Volumn 43, Issue SUPPL. 19, 2005, Pages 1-33

  Klossek, Jean Michel ^a   Chidiac, Christian ^a   Serrano, Elie ^a  

^a Study Group of Infectious Rhinosinusitis II

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFOTIAM HEXETIL; CEFPODOXIME PROXETIL; CEFTRIAXONE; CEFUROXIME AXETIL; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; METHYLTRANSFERASE; MOXIFLOXACIN; NORFLOXACIN; PENICILLIN G; PENICILLIN V; PRISTINAMYCIN; ROXITHROMYCIN; SPARFLOXACIN; TELITHROMYCIN; TROVAFLOXACIN; UNINDEXED DRUG; VASOCONSTRICTOR AGENT;

ALLERGY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASTHMA; BACTERIAL STRAIN; BACTERIAL SUPERINFECTION; BACTERIUM CULTURE; BRAIN DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; FRANCE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTICE; HAEMOPHILUS; HUMAN; IMMUNOPATHOLOGY; INFECTION RISK; MAXILLA SINUSITIS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA; NONHUMAN; ORBIT DISEASE; OTOSCOPY; RELAPSE; REVIEW; RHINOSINUSITIS; RISK ASSESSMENT; RISK REDUCTION; SHORT COURSE THERAPY; STAPHYLOCOCCUS; STREPTOCOCCUS; TREATMENT FAILURE;

EID: 29744432463     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (131)

1. AFSSAPS. Antibiothérapie par voie générale en pratique courante dans les infections respiratoires hautes de l'adulte et de l'enfant. October 2005. http://afssaps.sante.fr/htm/5/rbp/indrbp.htm
2. Aktas D, Kalcioglu MT, Kutlu R, Ozturan O, Oncel S. The relationship between the concha bullosa, nasal septal deviation and sinusitis. Rhinology. 2003; 41: 103-6
3. Albu S, Tomescu E, Bassat S, Merca Z. Intracranial complications of sinusitis. Acta Otorhinolaryngol Belg. 2001; 55: 265-72
4. Alos JI, Oteo J, Aracil B, Gomes-Garces JL. Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain. J Antimicrob Chemother. 2001; 48: 141-56
5. Barry B, Ameline E, Thuong M, Brunel F, Pichelin C, Gehanno P. Complications orbitaires des sinusites de l'adulte. Ann Otolaryngol Chir Cervicofac. 2000; 117: 19-25
6. Belafsky PC, Amedee R, Moore B, Kissinger PJ. The association between sinusitis and survival among individuals infected with the human immunodeficiency virus. Am J Rhinol. 2001; 15: 343-5
7. Bernal Sprekelsen M, Mosquera J, Til Perez G, Sandiumenge A, Cardesin Revilla A, Sabater Mata de la Barata F. Sinusitis in immunocompromised patients. A multicenter study. Acta Otorrinolaringol Esp. 2003; 54: 195-201
8. Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial rhinitis: a double-blind multicentre study. Rhinology. 1996; 34: 91-6
9. Biedenbach DJ, Jones RN. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2003; 46: 55-61
10. Blair C, Nelson M, Thompson K, Boonlayangoor S, Haney L, Gabr U, Baroody FM, Naclerio RM. Allergic inflammation enhances bacterial sinusitis in mice. J Allergy Clin Immunol. 2001; 108: 424-9
11. Boswell FJ, Andrews JM, Jevons G, Wise R. Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance. J Antimicrob Chemother. 2002; 50: 495-502
12. Boulesteix J, Bégué P, Dubreuil C, Mégraud F, Dabernat H, Geslin P, de La Rocque F, Trinh A. Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate. Infection. 1995; 23: S79-82
13. Bouvet Anne, Aubry-Damon Hélène, Péan Yves. Émergence de la résistance aux macrolides des Streptococcus pyogenes ou streptocoques bêta-hémolytiques du groupe A. BEH. 2004; 32-33: 154-5
14. Brook I, Frazier EH. Microbiology of recurrent acute rhinosinusitis. Laryngoscope. 2004; 114(1): 129-31
15. Buchanan PP, Stephens TA, Leroy B.A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis. Am J Rhinol. 2003; 17(6): 369-77
16. Burke TF, Guertler AT, Timmons JH. Comparison of sinus x-rays with computed tomography scans in acute sinusitis. Acad Emerg Med, 1994; 1: 235-9
17. Chaibi EB, Mugnier P, Kitzis MD, Goldstein FW, Acar JF. [beta]-Lactamases de Branhamella catarrhalis et leurs implications phénotypiques. Research Microbiology. 1995; 146: 761-71
18. Chardon H, Varon E, Bensaïd T, Bellon O, Lagier E, Gutmann L. Epidémiologie de la résistance au pneumocoque aux antibiotiques. Med Mal Inf. 2002; 32 (suppl 1): 21-31
19. Clayman GL, Adams GL, Paugh DR, Koopmann JR. Intracranial complications of paranasal sinusitis: a combined institutional review. Laryngoscope. 1991; 101: 234-9
20. Cohen R. Clinical efficacy of cefpodoxime in respiratory tract infection. J Antimicrob Chemother. 2002; 50: 23-7
21. Collet S, Bertrand B, Cornu S, Eloy P, Rombaux P. Is septal deviation a risk factor for chronic sinusitis? Review of literature. Acta Otorhinolaryngol Belg. 2001; 55: 299-304
22. Comité de l'Antibiogramme de la Société Française de Microbiologie. Report 2003. Int J Antimicrob Agents. 2003; 21:364-91
23. Conrad DA, Jenson HB. Management of acute bacterial rhinosinusitis. Curr Opin Pediatr. 2002; 14: 86-90
24. Dabernat H. Pristinamycine et Haemophilus influenzae: le point en 2000. Presse Med. 2000; 29: 2072-3
25. Dabernata H, Seguy M, Delmas C. Activité de 9 [bêta]-lactamines sur 280 souches de Haemophilus influenzae résistantes à l'ampicilline par bêtalactamase et mécanisme non enzymatique. Med Mal Inf. 2002; 32: 299-306
26. Dabernatb H, Seguy M, Delmas C. In vitro activity of telithromycin against Haemophilus influenzae. Pathol Biol (Paris). 2002; 50: 58-62
27. Dabernat H, Seguy M, Faucon G, Delmas C. Epidémiologie et évaluation de la sensibilité aux bêta-lactamines des souches de Haemophilus influenzae isolées en 2001 en France. Med Mal Inf. 2004; 34: 97-101
28. De Bock GH, van Erkel AR, Springer MP, Kievit J. Antibiotic prescription for acute sinusitis in otherwise healthy adults. Clinical cure in relation to costs. Scand J Prim Health Care. 2001; 19(1): 58-63
29. Decousser JW, Allouch PY, Courvalin P, Leclercq R. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey. Int J Antimicrob Agents. 2002; 20: 186-95
30. Dellamonica P, Pradier C, Leroy J, Carsenti-Etesse H, Dupont M. J, Roussel-Delvallez M, Dabernat H, Dunais B, Martinot A, Estavoyer J. M. Epidémiologie et sensibilité aux antibiotiques des souches nasopharyngées de S. pneumoniae et de H. influenzae d'enfants fréquentant les crèches de 3 départements français. Med Mal Inf. 2002; 32: 650-61
31. Dessi P, Castro F, Triglia JM, Zanaret M, Cannon M. Major complications of sinus surgery: a review of 1192 procedures. J Laryngol Otol. 1994; 108: 212-5
32. Doern G, Brueggemann A, Pierce G, Holley H Jr, Rauch A. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother. 1997; 41: 292-7
33. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW, Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. JAMA. 2001; 286 (24): 3097-105
34. Dorn M, Hofmann W, Knick E Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis. HNO. 2003; 51: 794-9
35. Druce HM. Diagnosis of sinusitis in adults: history, physical examination, nasal cytology, echo and rhinoscope. J Allergy Clin immunol. 1992; 90: 436-41
36. Drugeon HB. Activité in vitro du cefpodoxime sur Streptococcus pneumoniae: derniéres données françaises et revue de la littérature. Antibiotiques. 2004; 6:1-3
37. Drugeon HB, Juvin ME, Bensalah A, Moniot-Ville N et le groupe multicentrique. Épidémiologie de la résistance aux antibiotiques des pathogènes respiratoires en France en 2000-2001. Apport de la télithromycine. Med Mal Inf. 2003; 33: 104-9
38. Drugeon H, Juvin ME, Loncle-Provot V. Activité do céfotiamhéxétil sur des souches de Streptococcus pneumoniae de sensibilitié diminuée aux β-lactamines (PSDP): comparaison avec l'amoxicilline, le céfuroxime et le cefpodoxime. RICAI 2003; Abstract 338/49P
39. Drugeon HB. Activité bactéricide de la pristinamycine sur Streptococcus pneumoniae et Haemophilus influenzae. Journées Nationales d'Infectiologie. 2003; Lille, France. Abstract 99
40. Drugeon HB. Activité in vitro de la pristinamycine sur Streptococcus pneumoniae: bilan 2002. Poster 265/42p RICAl 2003.
41. Drugeon HB, Juvin ME, Bensalah A, Moniot-Ville et le groupe multicentrique. Sensibilité des trois principaux pathogènes respiratoires aux bêta-lactamines en France en 2000-2001. Résultats d'une étude muticentrique. Antibiotiques. 2002; 4: 193-6
42. Dubreuil C, Gehanno P, Goldstein F, Pancrazi J, Timsit C, Leblanc F, Meunier A, Chauveau. E. Sinusites maxillaires aiguës bactériennes de l'adulte: comparaison d'une durée de traitement de cinq jours versus dix jours par céfuroxime axétil. Med Mal Inf. 2001; 31: 61-9
43. Federspil P, Wulkow R, Zimmermann T. Effect of standardized Myrtol in therapy of acute sinusitis. Results of a double-blind, randomized multicenter study compared with placebo. Laryngorhinootologie. 1997; 76: 23-7
44. Ferrand PA, Mercier C, Jankowski R, Giroud C, Dellamonica P, Pasquier C, Touron D, Trinh A, Oriol V, Barbaza M. Sinusite aiguië de l'adulte: prise en charge par les médecins généralistes. Concours médical. 2000; 122 (41): 2974-5
45. Gehanno P, Goldstein F, Gutmann L, Klossek JM, Deschamps V, Dubrujeaud G, et le groupe d'étude français. Efficacité d'Augmenting® 1g/125 mg administré deux fois par jour dans le traitement des sinusites maxillaires aiguës. Med Mal Inf. 2000; 30: 703-13
46. Gehanno P, Beauvillain C, Bobin S, Chobaut J-C, Desaulty A, Dubreuil C, Klossek JM, Pessey JJ, Peyramond D, Strunski A, Chastang C. Short therapy with Amoxicillin - clavulanate and corticosteroid in acute sinusitis; results of a multicentre study in adults. Scand J Infect Dis. 2000; 32: 679-84
47. Gehanno P, Panajotopoulos A, Barry B, Nguyen L, Levy D, Bingen E, Berche P. Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr Infect Dis J. 2001; 20: 570-3
48. Gehanno P, Dubreuil C, Berche P, Safran C, Choné C. Traitement des sinusites maxillaires aiguës de l'adulte par le cefpodoxime proxétil: comparaison d'une durée de traitement de 5 jours versus 10 jours. Med Mal Inf. 2002; 32: 662-77
49. Gehanno P. Sinusites aiguës de l'adulte. La lettre de l'infectiologue. 2003; XVIII (1): 11-6
50. Gehanno P, Leboulanger N, Cohen R. Otite et sinusite, diminution de la morbidité et de la mortalité: rôle des antibiotiques ? La lettre d'ORL. 2003; 280: 3-4
51. Gehanno P, Berche P, Perrin A. Moxifloxacin in the treatment of acute maxillary sinusitis after first-line treatment failure and acute sinusitis with high risk of complications. J Int Med Res. 2003; 31: 434-47
52. Gehanno P, Berche P, Hercot O, d'Arras L, Cabrillac-Rives S, Derobeft E, Choné C. Efficacité comparée de la pristinamycine en 4 jours et du céfuroxime en 5 jours dans le traitement des sinusites maxillaires aiguës bactériennes de l'adulte. Med Mal Inf. 2004; 34(7): 293-302
53. Gehanno P, Berche P. Revue de 2076 patients inclus dans diverses études cliniques d'antibiothérapie entre 1988 et 2001. Submitted for publication
54. Gilger MA. Pediatric otolaryngologic manifestations of gastroesophageal reflux disease. Curr Gastroenterol Rep. 2003; 5: 247-52
55. Goldstein EJC, Citron DM, Merriam CV, Warren Y, Tyrrel KL, Fernandez H. In Vitro Activities of Telithromycin and 10 Oral Agents against Aerobic and Anaerobic Pathogens Isolated from Antral Puncture Specimens from Patients with Sinusitis. Antimicrob Agents Chemother. 2003; 47: 1963-7
56. Guay D. Short-course antimicrobial therapy of respiratory tract infections. Drugs 2003, 63, 2169-84
57. Gurney TA, Lee KC, Murr AH. Contemporary issues in rhinosinusitis and HIV infection. Curr Opin Otolaryngol Head Neck Surg. 2003; 11: 45-8
58. Halpern M, Schmier J, Richner R, Togias A. Antimicrobial treatment patterns, resource utilization and charges associated with acute sinusitis in asthma patients. Am J Health Syst Pharm. 2000; 57: 875-81
59. Hamdan AL, Bizri AR, Jaber M, Hammoud D, Baino T, Fuleihan N. Nasoseptal variation in relation to sinusitis. A computerized tomographic evaluation. J Med Liban. 2001; 49: 2-5
60. Henry DC, Riffer E, Sokol WN, Chaudry NI, Swanson RN. randomized double blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrob Agents Chemother. 2003; 47: 2770-4
61. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother. 2002; 50: 49-59
62. Houssaye S, Gutmann L, Varon E. Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother. 2002; 46: 2712-5
63. Jackson RM, Rice DH. Acute bacterial sinusitis and diabetes mellitus. Otolaryngol Head Neck Surg. 1987; 97: 469-73
64. Jones NS, Walker JL, Bassi S, Jones T, Punt J. The intracranial complications of rhinosinusitis: can they be prevented? Laryngoscope. 2002; 112: 59-63
65. Jones ME, Blosser-Middleton RS, Critchley IA. The activity of levofloxacin and comparator against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000. Chemotherapy. 2002; 48: 232-7
66. Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley IA, Thornsberry C, Sahm, DF. Apparent plateau in [beta]-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative. Int J Antimicrob Agents. 2002; 19: 119-23
67. Jones RN, Biedenbach DJ. Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001). Diagn Microbiol Infect Dis. 2003; 45: 273-8
68. Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis. 1992; 14: 1119-23
69. Kaliner M. Treatment of sinusitis in the next millenium. Allergy Asthma Proc. 1998; 19: 181-4
70. Karlowsky JA, Jones ME,Draghi DC, Sahm DF. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime. Antimicrob Agents Chemother. 2003; 47: 3155-60
71. Karlowsky JA, Thornsberry C, Critchley IA, Jones ME, Evangelista AT, Noel GJ, Sahm DF. Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States. Antimicrob Agents Chemother. 2003; 47: 1790-7
72. Klossek JM, Desmonts-Gohler C, Deslandes B, Coriat F, Bordure P, Dubreuil C, Gehanno P, Gilain L, Jankowski R, Serrano E, Stoll D. Treatment of functional signs of acute maxillary rhinosinusitis in adults. Efficacy and tolerance of administration of oral prednisone for 3 days. Presse Med. 2004; 33: 303-9
73. Klossek JM, Siegert R, Nikolaidis P, Arvis P, Leberre MA; Sinusitis Study Group. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults. J Laryngol Otol. 2003; 117: 43-51.
74. Klossek JM, Chidiac C, et le Groupe d'Etude des Sinusites Infectieuses (GESI) État actuel de la prise en charge de la sinusite ou rhino-sinusite aiguë maxillaire communautaire en France et revue de la littérature. Rhinology. 2001; suppl 17: 1-41
75. Lacassin F, Longuet P, Perronne C, Leport C, Gehanno P, Vilde JL. Sinusite infectieuse et SIDA: données cliniques et thérapeutiques à propos de 20 patients. Presse Med. 1993; 22: 899-902
76. Lang EE, Curran AJ, Patil N, Walsh RM, Rawluk D, Walsh MA. Intracranial complications of acute frontal sinusitis. Clin Otolaryngol. 2001; 26: 452-7
77. Laranne JE, Penttila MA, Paakkala TA, Pukander JS, Karma PH. Diagnostic value of plain radiographs in chronic maxillary sinusitis: a comparison between radiological and endoscopic finding in 75 patients. Rhinology. 1992; 30: 205-15
78. Laurans G, Murbach V, Cattier B. Observatoires régionaux du pneumocoque: surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France, en 1999. BEH. 2001; 33: 155-9
79. Leclercq R. Activité in vitro de la pristinamycine sur les germes respiratoires. Presse Med. 1999; 28 (Suppl. 1): 6-9
80. Lieu JE, Feinstein AR. Confirmations and surprises in the association of tobacco use with sinusitis. Arch Otolaryngol Head Neck Surg. 2000; 126: 940-6
81. Lindbaek M, Hjordahl P, Johnsen UL. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. Br Med J. 1996; 7053: 325-9
82. Linder JA, Singer DE. Health-related quality of life of adults with upper respiratory tract infections. J Gen Intern Med. 2003; 18: 802-7
83. Loehrl TA, Smith TL. Chronic sinusitis and gastroesophageal reflux: are they related? Curr Opin Otolaryngol Head Neck Surg. 2004; 12: 18-20
84. Lundberg L, Isacson D. The impact of over-the-counter availability of nasal sprays on sales, prescribing, and physician visits. Scan J Prim Care. 1999; 17: 41-5
85. Luterman M, Tellier G, Lasko B, Leroy B. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear Nose Throat J. 2003; 82: 576-90
86. Malm L. Pharmacological background to decongesting and anti-inflamatory treatment of rhinitis and sinusitis. Acta Otolaryngol Suppl. 1994; 515: 53-5
87. Maniglia AJ, Goodwin WJ, Arnold JE, Ganz E. Intracranial abscesses secondary to nasal, sinus and orbital infections in adult and children. Arch Otolaryngol Head Neck Surg. 1989; 115: 1424-9
88. Mariani-Kurkdjian P, Doit C, Deforche D, Brahimi N, François M, Van den Abbeele T, Bingen E. Émergence de la résistance à l'érythromycine et la clarithromycine chez Streptococcus pyogenes (SGA) responsable d'angine aiguë. RICAI 2003; abstract 327/49
89. Marshall AM, Jones NS. Osteomyelitis of the frontal bone secondary to frontal sinusitis. J Laryngol Otol. 2000; 114: 944-6
90. Meltzer EO, Charous BL, Busse WW, Zinreich SJ, Lorber RR, Danzig M. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. J Allergy Clin Immunol. 2000; 106: 630-37
91. Mortimore S, Wormald PJ. Management of acute complicated sinusitis: a 5-year review. Otolaryngol Head Neck Surg. 1999; 121: 639-42
92. Nayak AS, Settipane GA, Pedinoff A, Charous BL, Meltzer EO, Busse WW, Zinreich SJ, Lorber RR, Rikken G, Danzig MR. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol. 2002; 89: 271-8
93. Offfedo C, Gehanno P, Berche P. Epidémiologie de la flore nasopharyngée au cours des otites moyennes aiguës de l'enfant de décembre 2000 a mars 2001. Médecine et Maladies Infectieuses. 2003; 33: 93-103
94. Pessey JJ, Gehanno P, Dabernat H. Pristinamycine versus céfuroxime axétil dans le traitement de la sinusite aiguë de l'adulte. Med Mal Inf. 2001; 31 (6): 417-24
95. Pessey JJ, Coste A, Lemay-Bouzid D, Perret M, Barbaza MO. Répartition nosologique des épisodes de sinusites aiguës présumées infectieuses vues en pratique libérale par les ORL. Med Mal Inf. 2003; 33 (suppl. B): Poster D 03, 106
96. Pfleiderer AG, Croft CB, Lloyd GA. Antroscopy: its place in clinical practice. A comparison of antroscopic finding with radiographic appearances of the maxillary sinus. Clin Otolaryngol. 1986; 11: 455-61
97. Phipps CD, Wood WE, Gibson WS, Cochran WJ. Gastroesophageal reflux contributing to chronic sinus disease in children: a prospective analysis. Arch Otolaryngol Head Neck Surg. 2000; 126: 831-6
98. Pichiero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediat. Inf. Dis. J, 1997, 16, 680-95
99. Pothman R, Yeh HL. The effects of treatment with antibiotics, laser and acupuncture upon chronic maxillary sinusitis in children. Am J Chin Med. 1982; 10: 55-8
100. Rakkar S, Roberts K, Towe BF, Flores SM, Heyd A, Warner J. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. Int J Clin Pract. 2001; 55: 309-15
101. Reider JM, Nashelsky J. Do imaging studies aid diagnostics of acute sinusitis? J Fam Pract. 2003; 52(7): 565-7
102. Roos K, Brunswig-Pitschner C, Kostrica R, Pietola M, Leroy B, Rangaraju M, Boutalbi Y. Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis. Chemotherapy. 2002; 48: 100-8
103. Roth RP, Cantekin EI, Bluestone. Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol. 1997; 86: 235-42
104. Sahm DF, Jones ME, Hickey ML, Diakun DR, Mani SV, Thornsberry C. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J Antimicrob Chemother. 2000; 45: 457-66
105. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003; 36:131-9
106. Samolinski B, Zawisza E, Kaminski J, Kargul M. Évaluation de l'efficacité et de la tolérance de la fusafungine au cours des infections respiratoires hautes. Medical Science Monitor. 1996; 2: 650-6
107. Savolainen S. Allergy in patients with acute maxillary sinusitis. Allergy. 1989; 44: 116-22
108. Schito GC, Georgopoulos A, Prieto J. Antibacterial activity of oral antibiotics against community acquired respiratory pathogens from European countries. J Antimicrob Chemother. 2002; 50: 7-11
109. Schmitz FJ, Beeck A, Perdikouli M, Boos M, Mayer S, Scheuring S, Kohrer K, Verhoef J, Fluit A. C. Production of BRO {beta}-Lactamases and Resistance to Complement in European Moraxella catarrhalis Isolates. J Clin Microbiol. 2002; 40: 1546-8
110. Scott LJ, Ormrod D, Goa KL. Cefuroxime axetil: an updated review of its use in the management of bacterial infections. Drugs. 2001; 61(10): 1455-500
111. Soga Y, Oka K, Sato M, Kabata T, Kawasaki T, Kawano M, Hayano M. Cavernous sinus thrombophlebitis caused by sphenoid sinusitis. Report of autopsy case. Clin Neuropathol, 2001; 20: 101-5
112. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. Am J Med. 2001; 111: S19-24
113. Soussy CJ, Drugeon H, Goldstein F, Leclercq R, Weber P, Courvalin P. Actualisation du spectre d'activité antibactérienne du céfotiam hexétil. RICAII 2003
114. Soussy CJ. État actuel de la sensibilité de Streptococcus pneumoniae aux fluoroquinolones en France et dans le monde. Med Mal Inf. 2003; 33: 125-33
115. Stoll D. Inflammation rhinosinusienne aiguë. Presse Med. 2001; 30 (39-40): 33-40
116. Stoll D. Bébéar JP, Crampette L, Guerrier B, Gehanno P, Klossek JM, Pessey JJ, Serrano E, Peynegre R, Rugina M. Acute bacterial sinusitis: 43 cases of complications. 14th ECCMID - Prag. May 14, p 1675. 2004
117. Talon D, Leroy J, Dupont M. J, Bertrand X, Mermet F, Thouverez M, Estavoyer JM. Antibiotic susceptibility and genotypic characterization of Haemophilus influenzae strains isolated from nasopharyngeal specimens from children in day-care centers in eastern France. Clin Microbiol Infect. 2000; 6: 519-24
118. Theis J, Oubichon T. Are antibiotics helpful for acute maxillary sinusitis? J Fam Pract. 2003; 52(6): 490-2
119. Ulualp SO, Toohill RJ, Hoffmann R, Shaker R. Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol. 1999; 13: 197-202
120. Van Buchem FL, Knottnerus JA, Schnijremaekers VJJ, Peeters MF. Primary care based randomised placebo-controlled trial of antibiotic treatment in maxillary sinusitis. The Lancet. 1997; 349: 683-7
121. Varonen H, Sainio S. Patients' and physicians' views on the management of acute maxillary sinusitis. Scand J Prim Health Care. 2004; 22(1): 22-6
122. Vergnaud et coll. Observatoires régionaux du pneumocoque: analyse de la résistance aux antibiotiques et des sérotypes de Streptococcus pneumoniae en 2001. BEH. 2003; 37: 173-6
123. Weaver EM. Association between gastroesophageal reflux and sinusitis, otitis media, and laryngeal malignancy: a systematic review of the evidence. Am J Med. 2003; 115 (suppl): 81S-9S
124. Weber P, Filipecki J, Bingen E, Fitoussi F, Goldfarb G, Chauvin JP, Reitz C, Portier H. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother. 2001; 48: 291-4
125. Wiesenauer M, Gaus W, Bohnacker U, Haussler S. Efficiency of homeopathic preparation combinations in sinusitis. Results of a randomized double blind study with general practitioners. Arzneimittelforschung. 1989; 39: 620-5
126. Williams JW Jr, Aguilar C, Cornell J, Chiquette ED, Makela M, Holleman DR, Sirnel DL. Cochrane Database Syst Rev. 2003; (2): CD000243
127. World Health Organization, Overcoming antimicrobial resistance. World Health report on infectous diseases 2000. WHO/CDS/2000.2. Geneva: World Health Organization; 2000
128. Wurzer H, Heppt W, Weidauer H, Rosen-Wolff A, Hartmann M. Rhinosinusitis in AIDS patients. Laryngorhinootologie. 1995; 74: 188-90
129. Younis RT, Anand VK, Childress C. Sinusitis complicated by meningitis: current management. Laryngoscope. 2001; 11: 1338-42
130. Younis RT, Lazar RH, Bustillo A, Anand VK. Orbital infections as a complication of sinusitis: are diagnostic and treatment changing? Ear Nose Throat J. 2002; 81: 771-5
131. Younis RT, Lazar RH, Anand VK. Intracranial complications of sinusitis: a 15 years review of 39 cases. Ear Nose Throat J. 2002; 81: 640-2